Nektar Therapeutics logo

Nektar Therapeutics

Sector: 
Healthcare
   

Industry: 
Biotechnology

4.68
 
USD
  
-0.23
  
(-4.68%)
Optionable: Yes  Market Cap: 877 M  90-day average vol: 3,230,887

Previous close: 4.91  Open: 4.88  Bid: 4.92  Ask: 4.92
52 week range    
3.02   
   19.37
Peers   
PFE / 
MRK / 
AMGN / 
ENZN / 
BAX / 
JNJ / 
AZN / 
RELL / 
NVS / 
Last updated: Wednesday 17th August 2022
50
MarketXLS Rank marketxls
60
Value marketxls
46
Technical marketxls
44
Quality marketxls

Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONS

Get started today
Search for a stock
Are you?
twitterstocktwits
Metrics

Peers

StockDividendMarket Cap (B)PEPrice ($)

AFFY

AMGN

0.0347129 B23.4223.53

AZN

BAX

0.012943 B35.986.87

ENZN

0 B-10.30.3736

JNJ

0.0247450 B22.1171.06

MRK

0.0356207 B28.877.58

NVS

PFE

0.0302298 B15.153.21

RELL

0.01970 B1912.16
Chart
News
Trend Analysis & Forecast
Read more on this trend analysis & forecast here - uptrenddowntrend.com
Trendlast: 29.909


Financials

NKTR Income Statement

Annual

Dec-12Dec-13Dec-14Dec-15Dec-16Dec-17Dec-18Dec-19Dec-20Dec-21
Total revenues81 M149 M201 M231 M165 M308 M1,193 M115 M153 M102 M
Cost of sales16 M24 M16 M21 M15 M16 M14 M8 M5 M11 M
Gross operating profit51 M110 M172 M197 M135 M277 M1,169 M93 M133 M77 M
Selling Gen & administrative expense42 M41 M41 M43 M44 M52 M81 M99 M105 M123 M
Research & development expense149 M190 M148 M183 M204 M268 M400 M435 M409 M400 M
Operating income-140 M-120 M-16 M-29 M-113 M-44 M688 M-440 M-380 M-446 M
floaterest income0000000000
floaterest expense0000000000
Other income net-2 M392000135000-14 M0-16 M00-45 M-32 M
Pre-tax Income (EBT)-171 M-160 M-54 M-81 M-153 M-96 M683 M-440 M-444 M-523 M
Income taxes4060002 M-5120005060008760006160001 M613000493000557000
Net income from total operations-172 M-162 M-54 M-81 M-154 M-97 M681 M-441 M-444 M-524 M
Minority floaterest0000000000
Total net income-172 M-162 M-54 M-81 M-154 M-97 M681 M-441 M-444 M-524 M
Preferred dividendsN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Net income available for common-172 M-162 M-54 M-81 M-154 M-97 M681 M-441 M-444 M-524 M
Depreciation15 M14 M13 M13 M15 M15 M11 M13 M14 M14 M
Amortization0000000000
Operating income before depreciation (EBITDA)-123 M-105 M-3 M-29 M-95 M-40 M736 M-381 M-393 M-462 M
Total Income available for floaterest expense (EBIT)0000000000
Basic EPS total-1.5-1.4-0.42-0.61-1.1-0.624.02-2.52-2.49-2.86
Diluted EPS total-1.5-1.4-0.42-0.61-1.1-0.623.78-2.52-2.49-2.86
Top MarketXLS Rank stocks
Call: 1-877-778-8358Ankur Mohan
I am so happy you are here. My name is Ankur and I am the founder/CEO of MarketXLS. Over the past four years, I have helped more than 2500 customers to implement their own investment research strategies and monitoring systems in Excel.

Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONS

Get started today

Stand with Ukraine

As the situation in Ukraine escalates, many of us in MarketXLS are left with emotions too overwhelming to name. If you’d like to show your support, but aren’t sure how to, we want to help make it easier for you to act.

For any amount donated, we’ll extend your MarketXLS subscription for double of the donated amount. Please send proof of your payment to support@marketxls.com to avail the extention

From all of us at MarketXLS, thank you!